DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Sativa Group (NEX: SATI) CEO Henry Lees-Buckley joins DirectorsTalk to discuss its latest update to the market. Henry explains how two new appointments will help to strengthen its position, updates..
Cambria Automobiles (LON: CAMB) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. Mike explains how the results compare with forecasts, the key..
CentralNic Group (LON: CNIC) Chief Executive Officer Ben Crawford chats to DirectorsTalk about it’s latest acquisition of Team Internet for $45m. Ben explains what Team Internet does and how it..
Touchstone Exploration (LON: TXP) CEO Paul Baay joins DirectorsTalk to discuss test results at the COHO 1 well in Trinidad and Tobago. Paul talks us through the results, explains what’s..
TT Electronics plc (LON: TTG) CEO Richard Tyson joins DirectorsTalk to discuss its trading update to the end of October 2019. Richard explains why he is happy with the level..
NQ Minerals Plc (NEX: NQMI) (OTCQB: NQMLF) new Chairman David Lenigas joins DirectorsTalk to discuss his new role. David explains why he has joined the company, what investors can expect..
Avacta Group (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to update us on the collaboration with LG Chem. Alastair reminds investors of the details behind the collaboration, updates us on..
Jubilee Metals Group (LON: JLP) CEO Leon Coetzer joins DirectorsTalk to discuss it’s audited results for the year ended 30th June 2019. Leon gives an overview of the results, explains..
Advanced Oncotherapy plc (LON: AVO) is the topic of conversation when Dr Martin Hall, Head of Life Sciences at Hardman & Co joins DirectorsTalk. Martin talks us through some interesting..
Morses Club plc (LON: MCL) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was learnt from the recent results, details on..
Maestrano Group plc (LON: MNO) CEO Andrew Pearson joins DirectorsTalk to discuss the acquisition of Airsight Holdings. Andrew explains the new company business model, provides details on around the acquisition..
Arbuthnot Banking Group (LON: ARBB) are the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk. Mark explains what was said in the October statement, how new..
Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss product launches in both Halfords and on Amazon.com. Adrian explains what this means for the company, developments to..
Genedrive plc (LON: GDR) is the topic of conversation when Dr Dorothea Hill joins DirectorsTalk. After releasing a note anticipating accelerated news flow from Genedrive Dorothea gives us an update..
SmartSpace Software plc (LON: SMRT) CEO Frank Beechinor joins DirectorsTalk to discuss interim results, acquisition and placing. Frank talks us through the interim highlights, provides background and rationale behind the..
Volta Finance Limited (LON: VTAS) is the topic of conversation when Mark Thomas joins DirectorsTalk. Mark explains why the report is sat behind a disclaimer, talks us through his note,..
Nanoco Group plc (LON: NANO) CEO Michael Edelman joins DirectorsTalk to discuss highlights of the financial year end, the new market of IR sensing, the US customer, optimism in the..
Inchcape PLC (LON: INCH) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital talks to DirectorsTalk. Mike explains when he has recently published a new..
Avacta plc (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to discuss an agreement with ADC therapeutics. Alastair talks us through the agreement, explains what is expected from AVA6000 pro-doxorubicin in..
Tatton Asset Management (LON: TAM) is the topic of conversation when Robin Savage, Analyst at Zeus Capital joins DirectorsTalk. Robin reminds us of the services the company provides, talks us..
